Stock KALOBIOS PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar KaloBios Pharmaceuticals Inc Nasdaq

Equities

US48344T1007

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for KaloBios Pharmaceuticals Inc
12/04 Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. CI
08/03 Final DIP Financing Approved for Humanigen, Inc. CI

Chart calendar KaloBios Pharmaceuticals Inc

7f773882b2be15a506.cRrza95SBawSkVXHMFykSMGxXx3BYBLvox2T1Yuzn6A.AUqDNI81ZMBz5SyjBgvmDpDnM3yUK3qZ7XzRvtr36OcJYIFcuCNc4CujAA~a113a0292ba16bba0d39c73e95b7e45b

Upcoming events on KaloBios Pharmaceuticals Inc

No events available

Past events on KaloBios Pharmaceuticals Inc

14/04/2023 American Association for Cancer Research Meeting
17/11/2022 09:55 pm Jefferies London Healthcare Conference
14/11/2022 Q3 2022 Earnings Release
28/09/2022 06:30 pm Cantor Oncology, Hematology & HemeOnc Conference - Panel
13/09/2022 01:30 am H.C. Wainwright Global Investment Conference
13/08/2022 01:30 am Interim 2022 Earnings Release
21/06/2022 06:30 pm Lytham Partners Summer Investor Conference
10/06/2022 09:45 pm Jefferies Healthcare Conference
09/06/2022 10:30 pm Annual General Meeting
07/06/2022 09:30 pm LD Micro Invitational XII Conference
24/05/2022 08:30 pm H.C. Wainwright Global Life Sciences Investment Conference
11/05/2022 05:50 pm LSX World Congress - Panel
10/05/2022 08:15 pm LSX World Congress
06/05/2022 01:30 am Q1 2022 Earnings Release
28/03/2022 BIO Europe Spring Conference
28/03/2022 MedInvest Pharmaceutical and Biotechnology Investor Conference
16/03/2022 06:50 pm Oppenheimer Healthcare Conference
15/03/2022 09:30 pm Roth Capital Partners Conference
04/03/2022 07:30 pm Oppenheimer March Thought Leadership Series Conference
01/03/2022 01:30 pm Credit Suisse London Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,31
0,00
- 		3,60
2,95
22.05%		2,51
2,33
7.9%
EBITDA
Million USD		Released
Forecast
Spread 		0,00


-88,2
-93,1
5.22%		-233
-246
5.38%		-68,3
-75,7
9.78%
EBIT
Million USD		Released
Forecast
Spread 		0,00


-88,2
-92,6
4.76%		-233
-240
3.11%		-68,3
-80,9
15.58%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-89,5
-94,9
5.67%		-237
-245
3.42%		-70,7
-82,5
14.22%
Net income
Million USD		Released
Forecast
Spread 		-10,3


-89,5
-93,8
4.5%		-237
-243
2.48%		-70,7
-82,3
14.06%
EPS
USD		Released
Forecast
Spread 		-0,45


-2,42
-1,80
-34.51%		-4,04
-4,12
1.91%		-0,79
-1,02
22.3%
Announcement Date16/03/2010/03/2128/02/2230/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,49
0,00
- 		1,04
0,68
51.71%		1,04
0,07
1453.92%		1,04
0,42
146.9%		1,04
0,21
398.08%		1,04
0,35
198.84%		0,22
0,35
-36.25%		0,22
0,10
121%		0,22
0,00
-
EBITDA
Million USD		Released
Forecast
Spread 		-64,4
-31,3
-105.74%		-70,1
-44,3
-58.13%		-66,0
-68,3
3.4%		-32,3
-51,8
37.53%		-20,5
-35,6
42.33%		-29,4
-20,9
-40.44%		-22,7
-20,2
-12.76%		4,30
-1,88
328.56%


EBIT
Million USD		Released
Forecast
Spread 		-64,4
-34,4
-87.42%		-70,1
-48,4
-44.79%		-66,0
-58,3
-13.12%		-32,3
-39,5
18.19%		-20,5
-28,4
27.71%		-29,4
-22,2
-32.51%		-22,7
-11,2
-102.87%		4,30
-8,31
151.74%		-4,24
-17,2
75.38%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-65,6
-27,2
-141.23%		-70,8
-42,6
-66.05%		-66,7
-54,2
-23.18%		-33,5
-48,6
31.04%		-21,3
-31,9
33.3%		-30,1
-22,2
-35.91%		-23,7
-16,3
-45.45%		4,39
-7,57
157.99%		-4,18
-17,2
75.69%
Net income
Million USD		Released
Forecast
Spread 		-65,6
-33,6
-95.33%		-70,8
-47,8
-48.23%		-66,7
-56,7
-17.64%		-33,5
-44,4
24.52%		-21,3
-30,0
29.07%		-30,1
-22,4
-34.59%		-23,7
-17,8
-33.11%		4,39
-13,5
132.52%		-4,18
-17,2
75.69%
EPS
USD		Released
Forecast
Spread 		-1,25
-0,64
-95.31%		-1,20
-0,83
-44.1%		-1,12
-0,98
-13.71%		-0,53
-0,65
17.93%		-0,32
-0,46
30.93%		-0,43
-0,32
-34.38%		-0,23
-0,19
-22.67%		0,16
-0,06
352.64%		-0,04
-0,06
33.33%
Announcement Date13/05/2112/08/2112/11/2128/02/2205/05/2212/08/2214/11/2230/03/2315/05/23

Upcoming sector events for KaloBios Pharmaceuticals Inc

11/07/2024 11:30 am BONESUPPORT HOLDING AB: Q2 2024 Earnings Release
16/07/2024 SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release
23/07/2024 BIOGEN INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 11:30 am BIOGAIA AB: Q2 2024 Earnings Release
24/07/2024 SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected)
25/07/2024 PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected)
25/07/2024 GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected)
25/07/2024 10:30 am UCB: Q2 2024 Earnings Release
26/07/2024 SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected)
30/07/2024 BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for KaloBios Pharmaceuticals Inc

14/05/2024 09:05 pm GRIFOLS, S.A.: Q1 2024 Earnings Release
13/05/2024 ALTEOGEN INC.: Q1 2024 Earnings Release (Projected)
10/05/2024 PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release
10/05/2024 MEDY-TOX INC.: Q1 2024 Earnings Release
10/05/2024 01:35 am AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release
10/05/2024 01:35 am ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release
09/05/2024 12:00 pm NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release
09/05/2024 HUGEL, INC.: Q1 2024 Earnings Release
09/05/2024 01:46 am CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
09/05/2024 01:35 am ZAI LAB LIMITED: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. HGENQ Stock
  4. Stock
  5. Calendar KaloBios Pharmaceuticals Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW